CMC Conversations in Latin America
June 6, 2023
Session I has been postponed from 29 March 2023 to 6 June 2023.
Why Optimize the Submission and Review of CMC Post-Approval Changes? Global Trends and Challenges for Latin America
Post-approval changes (PAC) to the registered information of authorized medicinal products are routinely introduced worldwide, and their review represents a significant and increasing workload for regulators. Moreover, handling many different types of dossiers for the same product and managing change implementation worldwide is burdensome for industry. In Latin America, the diversity of CMC requirements and reporting change categories, regulatory gaps, and distinct procedures for PAC continue to represent a challenge, with potential impact on the availability of medicinal products in the region.
The first edition of the 2023 CMC Conversations in Latin America will be a virtual interactive session, gathering regulators and industry - from the region and beyond - to explore solutions in optimizing the submission, review and implementation process of CMC variations, focusing on convergence with international standards and adoption of best practices.
Session I - Tuesday, 6 June 2023
Why Optimize the Submission and Review of CMC Post-Approval Changes? Global Trends and Challenges for Latin America
Session II - Tuesday, 19 September 2023
Promoting Alignment to International Standards and Best Practices As the Way to Reduce Country-Specific Requirements and Streamline Regulatory Review
Session III - Tuesday, 7 November 2023
TBD during Session I